XML 52 R37.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Discontinued Operations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract] |
Schedule of discontinued operations | The following table summarizes the results of operations of the Company’s True Health business, which are included in loss from discontinued operations in the consolidated statements of operations and comprehensive income (loss) for the years ended December 31, 2021, 2020 and 2019:
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Revenue |  |  |  |  |
Platform and operations | $ | 38 |  |  | $ | 356 |  |  | $ | 145 |
Premiums | 44,795 |  |  | 117,377 |  |  | 171,742 |
Total revenue | 44,833 |  |  | 117,733 |  |  | 171,887 |
Expenses |  |  |  |  |
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below) (1) | 5,885 |  |  | 18,343 |  |  | 6,633 |
Claims expenses | 33,954 |  |  | 87,951 |  |  | 135,774 |
Selling, general and administrative expenses (2) | 5,764 |  |  | 18,576 |  |  | 26,617 |
Depreciation and amortization expenses | 160 |  |  | 640 |  |  | 590 |
Total operating expenses | 45,763 |  |  | 125,510 |  |  | 169,614 |
Operating income (loss) | (930) |  |  | (7,777) |  |  | 2,273 |
Interest income | 112 |  |  | 531 |  |  | 581 |
Interest expense | (4) |  |  | (12) |  |  | 21 |
Other loss | (25) |  |  | (1) |  |  | (3) |
Income (loss) before income taxes and non-controlling interests | (847) |  |  | (7,259) |  |  | 2,872 |
Benefit (provision) for income taxes | (326) |  |  | (1,185) |  |  | 1,259 |
Net income (loss) | $ | (521) |  |  | $ | (6,074) |  |  | $ | 1,613 |
———————— (1)Cost of revenue includes intercompany expenses between the Company and True Health that are recorded in income from continuing operations in the consolidated statements of operations and comprehensive income (loss) related to an existing services agreement for claims processing and other health plan administrative functions of $2.8 million, $13.6 million and $6.6 million for the years ended December 31, 2021, 2020 and 2019, respectively. (2)Selling, general and administrative expenses includes intercompany expenses between the Company and True Health that are recorded in income from continuing operations on the consolidated statements of operations and comprehensive income (loss) related to an existing services agreement for claims processing and other health plan administrative functions of $1.1 million, $6.4 million and $6.0 million for the years ended December 31, 2021, 2020 and 2019, respectively. Cash flows related to the True Health business during the year ended December 31, 2021, 2020 and 2019 were as follows:
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Cash flows provided by (used in) operating activities | $ | 5,002 |  |  | $ | 6,852 |  |  | $ | (6,642) |
Cash flows (used in) provided by investing activities | (2,494) |  |  | 2,636 |  |  | (7,172) |
Cash flows used in financing activities | — |  |  | — |  |  | (2,500) |
The following table summarizes the current and long-term assets and liabilities of the discontinued True Health business in the consolidated balance sheets as of December 31, 2020:
ASSETS |
Current assets: |
Cash and cash equivalents | $ | 21,488 |
Restricted cash and restricted investments | 63 |
Accounts receivable, net | 3,437 |
Prepaid expenses and other current assets | 5,198 |
Investments, at amortized cost | 3,728 |
Total current assets | 33,914 |
Restricted cash and restricted investments | 616 |
Investments, at amortized cost | 10,919 |
Prepaid expenses and other noncurrent assets | 59 |
Intangible assets, net | 3,080 |
Goodwill | 5,705 |
Total assets | $ | 54,293 |
LIABILITIES |
Current liabilities: |
Accounts payable (1) | 93 |
Accrued liabilities | 11,265 |
Accrued compensation and employee benefits | 1,115 |
Deferred revenue | 4,140 |
Reserve for claims and performance-based arrangements | 9,858 |
Total current liabilities | 26,471 |
Other long-term liabilities | 128 |
Deferred tax liabilities, net | 49 |
Total liabilities | $ | 26,648 |
———————— (1)Accounts payable excludes $1.5 million between the Company and True Health related to an existing services agreement for claims processing and other health plan administrative functions as of December 31, 2020.

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3A -URI http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5D -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 3A -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760 Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760 Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5A -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760 Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760 Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 4A -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760 + Details
Name: | us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration